Company Filing History:
1 out of 17 
1 out of 1 
1 out of 11 Years Active: 2012
Title: Jorge Elias Kalil Filho: Innovator in Anti-HIV Immunogens
Introduction
Jorge Elias Kalil Filho is a prominent inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology, particularly in the development of anti-HIV immunogens. His work focuses on innovative methods for inducing immune responses against the HIV-1 virus.
Latest Patents
Kalil Filho holds a patent for "Anti-HIV immunogens and methods for inducing an immune response." This invention introduces new epitopes recognized by CD4+ T-lymphocytes. The patent outlines the uses of these epitopes and their combinations, especially in the treatment or prevention of disorders caused by the HIV-1 virus. Additionally, it describes a composition comprising these epitopes and their applications in therapeutic and prophylactic vaccines against HIV-1. The invention also includes methods for identifying epitopes and strategies for treating or preventing HIV-1 infections. He has 1 patent to his name.
Career Highlights
Throughout his career, Kalil Filho has worked with notable institutions, including the Fundação de Amparo à Pesquisa do Estado de São Paulo and the Fundação Zerbini. His research has significantly advanced the understanding of immune responses to HIV.
Collaborations
Kalil Filho has collaborated with esteemed colleagues such as Edecio Cunha Neto and Simone Goncalves Da Fonseca. Their joint efforts have contributed to the development of innovative solutions in the fight against HIV.
Conclusion
Jorge Elias Kalil Filho's work in the field of immunology, particularly regarding anti-HIV immunogens, showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against HIV, and his innovative approaches continue to inspire future research.